6533b873fe1ef96bd12d4a7e
RESEARCH PRODUCT
Rivaroxaban in Peripheral Artery Disease after Revascularization
Rupert BauersachsEva MuehlhoferAkos F. PapE Sebastian DebusManesh R. PatelJohn KittelsonMarc P. BonacaConnie N. HessDainis KrievinsSonia S. AnandIvan GudzMarianne BrodmannLihong DiaoNicole JaegerFabrizio FanelliLajos MátyásRafael DiazMark R. NehlerWilliam R. HiattWarren H. CapellLloyd HaskellScott D. Berkowitzsubject
RivaroxabanAspirinmedicine.medical_specialtyArterial diseasebusiness.industrymedicine.medical_treatmentGeneral MedicineDisease030204 cardiovascular system & hematologyRevascularizationlaw.invention03 medical and health sciences0302 clinical medicinePharmacotherapyRandomized controlled trialMulticenter studylawInternal medicineCardiologyMedicine030212 general & internal medicinebusinessmedicine.drugdescription
Abstract Background Patients with peripheral artery disease who have undergone lower-extremity revascularization are at high risk for major adverse limb and cardiovascular events. The efficacy and ...
year | journal | country | edition | language |
---|---|---|---|---|
2020-05-21 | New England Journal of Medicine |